Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Quotient is a medical devices business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 450 staff and has a trailing 12-month revenue of around $37.6 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $0.06 |
|---|---|
| 52-week range | $0.06 - $68.80 |
| 50-day moving average | $0.66 |
| 200-day moving average | $9.22 |
| Wall St. target price | $60.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.34 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.055 from 2023-02-07
| 1 week (2023-02-02) | -25.88% |
|---|---|
| 1 month (2023-01-09) | -80.43% |
| 3 months (2022-11-09) | -96.56% |
| 6 months (2022-08-09) | -77.08% |
| 1 year (2022-02-09) | -96.47% |
|---|---|
| 2 years (2021-02-09) | -98.92% |
| 3 years (2020-02-07) | 7.13 |
| 5 years (2018-02-09) | 144 |
| Revenue TTM | $37.6 million |
|---|---|
| Gross profit TTM | $14.9 million |
| Return on assets TTM | -40.28% |
| Return on equity TTM | -737.71% |
| Profit margin | 0% |
| Book value | $-53.62 |
| Market capitalisation | $1.3 million |
TTM: trailing 12 months
We're not expecting Quotient to pay a dividend over the next 12 months.
Quotient's shares were split on a 1:40 basis on 2 November 2022. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Quotient shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Quotient shares which in turn could have impacted Quotient's share price.
Over the last 12 months, Quotient's shares have ranged in value from as little as $0.06 up to $68.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.1915. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. .
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.